Franco Manca owner expanding in anticipation of reopenings

Fulham Shore (FULH.L) is a small-cap restaurant owner listed on the AIM market. They have two main brands in Franco Manca and The Real Greek operating predominantly in the UK. Franco Manca is a pizzeria chain focused on providing high-quality sourdough Neapolitan pizzas and The Real Greek serves a variety of modern Greek and Eastern Mediterranean cuisine.

Between these brands, Fulham Shore currently operates 72 sites with plans to open 3 more by summer 2021, taking advantage of the global pandemic lowering rent on commercial highstreet properties. This expansion places them well to benefit from the anticipated […]

By |2021-02-12T00:01:11+05:30Friday, February 12, 2021|Categories: Ahead|Tags: , , , , |0 Comments

“Green revolution” to cause rare-earth boom

The global push to promote environmentally sustainable technologies presents one of the most potentially enticing opportunities for investors in a generation.  Most major governments have either already set or are in the process of setting target dates for the phasing out of fossil fuel dependant vehicles and electricity production. Two industries that will in all likelihood benefit greatly from this are the electric vehicle (EV) industry and the wind turbine industry. However, given the direct nature of this benefit, share prices of companies in these industries, such as Tesla, usually have this future demand priced in. While there […]

Premier Inn owner stock may spike at lockdown’s end

UK based hospitality company Whitbread PLC (WTB.L) is one of the many hospitality firms patiently waiting for an end to lockdown. While essentially the entire hospitality business has been damaged by national lockdowns and restrictions on travel, they will likely see a recovery once restrictions are lifted. Whitbread is in a potentially advantageous position in this situation being able to benefit twice from the lift of lockdown. Being the largest hotel brand in the UK, owning Premier Inn, and also owning significant restaurant/pub brands in Beefeater, Table Table & Brewer’s Fayre, they look poised to benefit from […]

By |2021-02-10T01:28:04+05:30Wednesday, February 10, 2021|Categories: Ahead, Around Blighty|Tags: , , , |0 Comments

Are GE’s fortunes finally on the turnaround?

Recent memory has turned the story of General Electric (GE.N) from classic success story to a near tragedy. Founded in the 1890s, GE is one of the oldest recognisable businesses in the world and for the majority of their existence, they were successful. They were one of the founding members of the Dow Jones Industrial average and were the only remaining founding member until they were replaced in 2018 by Walgreen Boots. 

Like many businesses, they were hurt badly by the onset of the global pandemic. Their most profitable sector at the time, GE Aviation, changed […]

By |2021-02-09T00:02:50+05:30Tuesday, February 9, 2021|Categories: Ahead|Tags: , , , , |0 Comments

Coca-Cola stock still low but rally seems inevitable

It’s common knowledge that many large companies suffered when the global pandemic hit. Stock prices plummeted around the board as national lockdowns closed businesses around the world. While many larger companies have been able to adapt over the last year and their market prices have more or less rallied to pre-pandemic levels, one notable exception stands out. 

Shares in Coca-Cola’s European bottling company Coca-Cola HBC (CCH.L) still remain 15% lower than they were last year. Given they are extensively a non-alcoholic beverage producer, there were inherent limits on how much they could adapt. National lockdowns brought […]

By |2021-02-05T22:50:53+05:30Friday, February 5, 2021|Categories: Ahead|Tags: , , |0 Comments

Jazz Pharmaceutical join growing medical cannabinoid industry

Yesterday Jazz Pharmaceutical (JAZZ.OQ) announced a £5.3B deal to takeover Cambridge based GW pharmaceuticals. Jazz currently has a wide portfolio of drugs focused on sleep, haematology and oncology therapies. This acquisition will add GW’s epilepsy drug Epidolex and MS drug to their portfolio but more excitingly it gives them access to the largest infrastructure for the production and processing of medical cannabis in the UK, one of the worlds largest exporters of cannabis-derived medicines

The medical cannabis market is expected to grow significantly over the next 5-10 years as more countries around the world start to […]

By |2021-02-05T01:03:01+05:30Friday, February 5, 2021|Categories: Ahead|Tags: , , , , |0 Comments
Load More Posts